On the other hand, NDRG3 expression is frequently upregulated in many cancer types, including prostate cancer, hepatocellular carcinoma, nonsmall cell lung cancer, breast cancer, and colorectal cancer, in association with aggressive cancer phenotypes and a poor prognosis [5,6,7,8,9,10]. The gene discussed is NDRG3; the disease is prostate carcinoma.